Tibet Rhodiola Pharmaceutical Holding Co. (SHA:600211)
China · Delayed Price · Currency is CNY 38.00
+2.40 (6.74%)
Jun 29, 2026, 3:00 PM CST
SHA:600211 Market Cap
SHA:600211 has a market cap or net worth of 12.1 billion as of June 29, 2026. Its market cap has increased by 1.32% in one year.
Market Cap
12.10B
Enterprise Value
9.66B
Revenue
2.99B
Ranking
n/a
PE Ratio
12.67
Stock Price
38.00
Market Cap Chart
Since October 20, 1999, SHA:600211's market cap has increased from 1.45B to 12.10B, an increase of 735.34%. That is a compound annual growth rate of 8.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 12.10B | -11.80% |
| Dec 31, 2025 | 13.71B | 15.19% |
| Dec 31, 2024 | 11.91B | -1.59% |
| Dec 29, 2023 | 12.10B | 35.86% |
| Dec 30, 2022 | 8.91B | -31.40% |
| Dec 31, 2021 | 12.98B | -22.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Wedge Industrial | 13.34B |
| Shenzhen Kangtai Biological Products | 12.93B |
| Beijing Aosaikang Pharmaceutical | 12.52B |
| Shenzhen Hepalink Pharmaceutical Group | 12.22B |
| Guobang Pharma | 12.18B |
| Zhejiang Hisun Pharmaceutical | 11.98B |
| Zhejiang Jiuzhou Pharmaceutical | 11.97B |
| Nanjing King-Friend Biochemical Pharmaceutical | 11.72B |